The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia

Best Practice and Research in Clinical Haematology

Volumn 20, Issue 3, 2007, Pages 425-437

  Calin, George A ^a   Pekarsky, Yuri ^a   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

BCL2; CLL; microarray profiling; microRNAs; TCL1

Indexed keywords

B LYMPHOCYTE RECEPTOR; GENE PRODUCT; IMMUNOGLOBULIN HEAVY CHAIN; MICRORNA; MICRORNA 15A; MICRORNA 16 1; PROTEIN BCL 2; PROTEIN KINASE ZAP 70; PROTEIN TCL 1; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CANCER GROWTH; CHROMOSOME 13Q; CHRONIC LYMPHATIC LEUKEMIA; DOWN REGULATION; GENE LOCATION; GENETIC DISORDER; HEREDITY; HUMAN; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW;

ANIMALS; DOWN-REGULATION; GENES, BCL-2; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MICE; MICE, TRANSGENIC; MICRORNAS; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 34547854381     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2007.02.003     Document Type: Review

References (63)

1. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
3. Cullen B.R. Transcription and processing of human microRNA precursors. Molecular Cell 16 (2004) 861-865
4. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113 (2003) 673-676
5. Lim L.P., Glasner M.E., Yekta S., et al. Vertebrate microRNA genes. Science 299 (2003) 1540
6. Berezikov E., Guryev V., van de Belt J., et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120 (2005) 21-24
7. Xie X., Lu J., Kulbokas E.J., et al. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434 (2005) 338-345
8. Harfe B.D. MicroRNAs in vertebrate development. Current Opinion in Genetics & Development 15 (2005) 410-415
9. Calin G.A., Ferracin M., Cimmino A., et al. A unique microRNA signature associated with prognostic factors and disease progression in B cell chronic lymphocytic leukemia. The New England Journal of Medicine 352 (2005) 1667-1676
10. Kluiver J., Poppema S., de Jong D., et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. The Journal of Pathology 207 (2005) 243-249
11. Eis P.S., Tam W., Sun L., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 3627-3632
12. Costinean S. Pre B cell proliferation and lymphoblastic leukemia/high grade lymphoma in Emiu miR 155 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 7024-7029
13. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 2999-3004
14. Calin G.A., Garzon R., Cimmino A., et al. MicroRNAs and leukemias: how strong is the connection?. Leukemia Research 30 (2005) 653-655
15. Sevignani C., Calin G.A., Siracusa L.D., and Croce C.M. Mammalian microRNAs: a small world for fine-tuning gene expression. Mammalian Genome 17 (2006) 189-202
16. Di Leva G., Calin G.A., and Croce C.M. MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Research. Part C, Embryo Today: Reviews 78 (2006) 180-189
17. Chiorazzi N., Rai K.R., and Ferrarini M. Chronic lymphocytic leukemia. The New England Journal of Medicine 352 (2005) 804-815
18. Rassenti L.Z., Huynh L., Toy T.L., et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. The New England Journal of Medicine 351 (2004) 893-901
19. Orchard J.A., Ibbotson R.E., Davis Z.A., et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363 (2004) 105-111
20. Kipps T.J. Chronic lymphocytic leukemia and related diseases. In: Beutler E., Lichtman M.A., Coller B.S., Kipps T.J., and Seligson U. (Eds). Williams hematology (2001), McGraw-Hill, New York 1163-1194
21. Dohner H., Stilgenbaue S., Benner A., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. The New England Journal of Medicine 343 (2000) 1910-1916
22. Calin G.A., Dumitru C.D., Shimizu M., et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 15524-15529
23. Stilgenbauer S., Nickolenko J., Wilhelm J., et al. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 16 (1998) 1891-1897
24. Elnenaei M.O., Hamoudi R.A., Swansbury J., et al. Delineation of the minimal region of loss at 13q14 in multiple myeloma. Genes Chromosomes & Cancer 36 (2003) 99-106
25. Dong J.T., Boyd J.C., and Frierson Jr. H.F. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 49 (2001) 166-171
26. Kitada S., Andersen J., Akar S., et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood 91 (1998) 3379-3389
27. Adachi M., Tefferi A., Greipp P.R., et al. Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. The Journal of Experimental Medicine 171 (1990) 559-564
28. Cory S., and Adams J.M. The BCL2 family: regulators of the cellular life-or-death switch. Nature Reviews 2 (2002) 647-656
29. Sanchez-Beato M., Sanchez-Aguilera A., and Piris M.A. Cell cycle deregulation in B-cell lymphomas. Blood 101 (2003) 1220-1235
30. Tsujimoto Y., Finger L.R., Yunis J., et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226 (1984) 1097-1099
31. Tsujimoto Y., Cossman J., Jaffe E., and Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 (1985) 1440-1443
32. Cimmino A., Calin G.A., Fabbri M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 13944-13949
33. Cheson B.D., Bennett J.M., Grever M., et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 15 (1996) 4990-4997
34. Pekarsky Y., Santanam U., Cimmino A., et al. Tcl1 expression in CLL is regulated by miR-29 and miR-181. Cancer Research 66 (2006) 11590-11593
35. Virgilio L., Narducci M.G., Isobe M., et al. Identification of the TCL1 gene involved in T-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America 91 (1994) 12530-12534
36. Pekarsky Y., Calin G.A., Aqeilan R., and Croce C.M. Chronic lymphocytic leukemia: molecular genetics and animal models. Current Topics in Microbiology and Immunology 294 (2005) 51-70
37. Herling M., Patel K.A., Khalili J., et al. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 20 (2006) 280-285
38. Narducci M.G., Pescarmona E., Lazzeri C., et al. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Research 60 (2000) 2095-2100
39. Said J.W., Hoyer K.K., French S.W., et al. TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Laboratory Investigation 81 (2001) 555-564
40. Pekarsky Y., Koval A., Hallas C., et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 3028-3033
41. Laine J., Kunstle G., Obata T., et al. The protooncogene TCL1 is an Akt kinase coactivator. Molecular Cell 6 (2000) 395-407
42. Chan T.O., Rittenhouse S.E., and Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annual Review of Biochemistry 68 (1999) 965-1014
43. Pekarsky Y., Hallas C., and Croce C.M. The role of TCL1 in human T-cell leukemia. Oncogene 20 (2001) 5638-5643
44. Palamarchuk A., Efanov A., Maximov V., et al. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Research 65 (2005) 11282-11286
45. Ozes O.N., Mayo L.D., Gustin J.A., et al. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401 (1999) 82-85
46. Cross D.A., Alessi D.R., Cohen P., et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
47. Du K., and Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. The Journal of Biological Chemistry 273 (1998) 32377-32379
48. Mok C.L., Gil-Gomez G., Williams O., et al. Bad can act as a key regulator of T cell apoptosis and T cell development. The Journal of Experimental Medicine 189 (1999) 575-586
49. Palamarchuk A., Zanesi N., Aqeilan R.I., et al. Tal1 transgenic expression reveals absence of B lymphocytes. Cancer Research 66 (2006) 6014-6017
50. Ahmed N.N., Franke T.F., Bellacosa A., et al. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene 8 (1993) 1957-1963
51. Bichi R., Shinton S.A., Martin E.S., et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 6955-6960
52. Hoyer K.K., French S.W., Turner D.E., et al. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 14392-14397
53. Zanesi N., Aqeilan R., Drusco A., et al. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in E{micro}-TCL1 transgenic mice. Cancer Research 66 (2006) 915-920
54. Robak T. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia. Hematology (Amsterdam, Netherlands) 9 (2004) 387-400
55. Yan X.J., Albesiano E., Zanesi N., et al. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 11713-11718
56. Chiorazzi N., and Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annual Review of Immunology 21 (2003) 841-894
57. H1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. Journal of Immunology (Baltimore, Md) 158 (1997) 235-246
58. Ghiotto F., Fais F., Valetto A., et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. The Journal of Clinical Investigation 113 (2004) 1008-1016
59. Griffiths-Jones S., Grocock R.J., van Dongen S., et al. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research Database Issue (2006) D140-D144
60. Calin G.A., Liu C.G., Sevignani C., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 11755-11760
61. Calin G.A., Ferracin M., Cimmino A., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England Journal of Medicine 353 (2005) 1793-1801
62. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004) 83-86
63. Ramkissoon S.H., Mainwaring L.A., Ogasawara Y., et al. Hematopoietic-specific microRNA expression in human cells. Leukemia Research 30 (2006) 643-647